uPAR: A Promising Novel Radiopharmaceutical Target for Solid Tumors
Time: 9:30 am
day: Conference Day One
Details:
- Revealing why uPAR is a promising radiopharma target and what characteristics make it particularly appealing
- Sharing the strategy that went into creating Monopar’s targeting agent against uPAR
- Optimizing biodistribution preclinically and how that translated
